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Brief Reports 
Four Period Crossover Designs 
 
James F. Reed III 
Christiana Care Hospital System, 
Newark, Delaware 
 
 
In higher-order four period crossover designs with two treatments, sixteen possible treatment sequences 
can result: AAAA, AAAB, AABA, AABB, ABAA, ABAB, ABBA, ABBB and their duals. Higher-order 
crossover designs are useful for several reasons: they allow estimation of a treatment effect even in the 
presence of a carry-over effect, they provide estimates of intra-subject variability and they draw inference 
on the carry-over effect. The real question related to a two-treatment four-period crossover design is the 
real world application of these designs. This article considers four designs: Design I: ABBA and its dual; 
Design II: ABBA, AABB and their duals, Design III: ABBA, ABAA and their duals, Design IV: ABBA, 
ABAB and their duals. A traditional model that specifies a first-order carryover effect is assumed and 
methods for estimating treatment and first-order carryover effects in the set of four period trials are 
outlined. 
 
Key words: Four period crossover design, carryover effect, bioequivalence. 
 
 
Introduction 
The crossover design, which compares two 
treatments over two periods, has held a 
dominant position in the application of crossover 
designs to the extent that – in the majority of 
articles and texts – it is referred to as the 
crossover design. Crossover designs are popular 
for comparing several non-curative treatments 
for their efficacy. For convenience, a crossover 
design with t treatments, p periods and s 
sequences is denoted as a C (t, p, s).  
Critiques of the C (2, 2, 2) with 
sequences AB and BA are well known; the most 
serious of these is that the carryover effect is 
confounded with sequence by period effects 
leading to erroneous analyses. To overcome the 
disadvantages of the C (2, 2, 2), a higher-order 
crossover design may be used. Two strategies 
can  be  employed  to  overcome  the  problems 
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inherent in the C (2, 2, 2) design. The first 
strategy is to extend the number of sequences, 
such as Balaam’s C (2, 2, 4) design (Balaam, 
1968); this design has four sequences, 
AA|AB|BA|BB. In addition, unbiased estimates 
of treatment and carryover effect can be 
formulated using a strategy outlined by 
Matthews (Matthews, 1994; Laska, Meisner & 
Kushner, 1983; Reed, 2010). The second 
strategy is to extend the classic design by adding 
a third period and/or a fourth period and 
repeating one of the two treatments. 
Higher-order four period crossover 
designs with two treatments can result in sixteen 
possible treatment sequences: AAAA, AAAB, 
AABA, AABB, ABAA, ABAB, ABBA, ABBB 
and their duals. This article considers four 
designs: Design I: ABBA and its dual; Design 
II: ABBA, AABB and their duals, Design III: 
ABBA, ABAA and their duals, Design IV: 
ABBA, ABAB and their duals. This article 
presents methods for estimating treatment and 
first-order carryover effects in the set of four 
period trials, assuming a traditional model that 
specifies a first-order carryover effect. 
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Crossover Design Model with Continuous Data 
Assume that the primary goal is to 
compare two treatments A and B used in a study 
by estimating the treatment contrast τA – τB and 
period effects π1 and π2; first order carryover 
effects λA, λB and μ are regarded as nuisance 
parameters. Also assume that the response 
variable is continuous and that there is one 
response from each subject in each period. 
Finally, it is assumed that each treatment has a 
simple first-order carryover effect that does not 
interact with the direct effect of the treatment in 
the subsequent period. This model then assumes 
the following for the response of patient yij. 
If yijk denotes the observed response of 
subject j (j = 1, …, n) in period i (i = 1, …, p), 
then 
 
ijk i d(i,j) d(i-1,j) j ijy µ + π + τ + λ + β + ε ,=  
 
where πi is the effect of period I, τd(i,j) is the 
direct effect of treatment D, λd(i-1,j) is the simple 
first-order carryover effect of treatment D, and 
d(i,j) is the treatment allocated to patient j in 
period i. λd(0,j) = 0 for all j. It is assumed that all 
effects are fixed effects. βj is the effect of patient 
j and εij is the error term. The random subject 
effect, βj, and the experimental error, εij, are 
assumed to be mutually independently 
distributed as N (0, σ2β) and N (0, σ2ε). 
 
Design I: ABBA and Its Dual 
An optimal two-sequence three period 
crossover design is the ABB/BAA design (Laska 
& Meisner, 1985; Hedayat & Stufken, 2003). 
This design is sometimes referred to as the two-
sequence dual design because it allows an 
estimate of both treatment and carryover effect. 
The first design considered extends this by 
adding a fourth period and considering the 
sequence ABBA and its dual (see Table 1). 
In sequence ABBA, the contrast, c1= y11 
+ 2y12 + y13 + y14 has expectation 5μ + (π1 + 2 π2 
+ π3 + π4) + (2τA +3 τB) + (2λA+2 λB). In 
sequence BAAB, the contrast c2 = y21 + 2y22 + 
y32 - y42 has expectation 5μ + (π1 + 2 π2 + π3 + 
π4) + (2τB +3 τA) + (2λA+2 λB). The difference 
between contrast c1 and c2 forms an unbiased 
estimator of τA − τB. For the construction of an 
unbiased estimator of any carryover effect, λA - 
λB, consider c3 = y11 - y12 + y13 - y14 and c4 = y21 
− y22 + y32 - y42. The difference between c3 and 
c4 forms an unbiased estimate of λA − λB. Note 
that if the last period is omitted, this design 
reduces to an optimal two-sequence dual design. 
If the last two periods are eliminated, the design 
becomes the standard AB/BA crossover design. 
 
Design II: ABBA, AABB and Their Duals 
This four-sequence, four-period design 
is a combination of two Balaam designs. The 
first two periods are the same as Balaam’s 
design, while periods 3 and 4 are copies of 
Balaam’s design reversed (see Table 2). 
In sequence ABBA, the contrast c1= y11 
+ y12 − y13 + y14 has expectation 2μ + (π1 + π2 - 
π3 + π4) + (2τA +λA). In AABB, the contrast c2 = 
y21 + y22 - y23 − y24 has expectation 2μ + (π1 + 2 
π2 − π3 + π4) + (2τA + λB). In sequence BAAB, 
the contrast c3 = y31 + y32 − y33 − y34 has 
expectation 2μ + (π1 + 2 π2 − π3 + π4) + (2τB + 
λB), and in BBAA the contrast c4 = y41 + y22 − 
y43 − y44 has expectation 2μ + (π1 + 2 π2 − π3 + 
π4) + (2τB + λA). A combination of (c1 − c4) + (c2 
− c3) forms an unbiased estimate of treatment 
effect (τA − τB). 
In sequence ABBA, the expected value 
of E[c5] = E[y11 + 2y12 + y13 + y14] = 5μ + (π1 + 
2π2 + π3 + π4) + (2τA + 3τB) + (2λA+ 2λB); in 
AABB, the expected value of E[c6] = E[y21 + 
2y22 + y23 − y24] = 5μ + (π1 + 2π2 + π3 + π4) + 
(3τA + 2τB) + (3λA+ λB); in BAAB, the expected 
value of E[c7] = E[y31 + 2y32 + y33 − y34] = 5μ + 
(π1 + 2π2 + π3 + π4) + (2τB + 3τA) + (2λA+ 2λB); 
and in BBAA, the expected value of E[c8] = 
E[y41 + 2y22 + y43 − y44] = 5μ + (π1 + 2π2 + π3 + 
π4) + (3τB + 2τA) + (λA+ 3λB). A combination of 
(c1 − c3) + (c2 − c4) forms an unbiased estimate 
of treatment effect (λA − λB). 
 
Design III: ABBA, ABAA and Their Duals 
In sequences ABBA, ABAA, BAAB, 
and BABB the expected values of E[c1], E[c2], 
E[c3] and E[c4] are: E[y11 + y12 + y13 − y14] = 2μ 
+ (π1 + π2 + π3 − π4) + (2τB +λA), E[y21 + y22 + 
y23 − y24] = 2μ + (π1 + π2 + π3 − π4) + (τA + τB - 
λA + λB), E[y31 + y32 + y33 − y34] = 2μ + (π1 + π2 
+ π3 − π4) + (2τA + λB) and E[y41 + y22 + y43 − 
y44] = 2μ + (π1 + π2 + π3 − π4) + (τA + τB + λA − 
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λB), respectively (see Table 3). The linear 
combination of (c1 − c4) - (c2 − c3) forms an 
unbiased estimate of treatment effect (λA − λB), 
while the linear combination of 2(c1 − c3) + (c2 − 
c4) forms an unbiased estimate of treatment 
effect (τA − τB). 
 
Design V: ABBA, ABAB and Their Duals 
In sequence ABBA, the expected value 
of E[c1] = E[y11 − y12 + y13 + y14] = 2μ + (π1 − π2 
+ π3 + π4) + (2τA + λB − λA); in ABAA, the 
expected value of E[c2] = E[y21 − y22 + y23 + y24] 
= 2μ + (π1 − π2 + π3 + π4) + (2τA + λB). For 
sequence BAAB, the expected value of E[c3] = 
E[y31 − y32 + y33 + y34] = 2μ + (π1 − π2 + π3 + π4) 
+ (2τB + λA − λB), and in BABB, the expected 
value of E[c4] = E[y41 − y22 + y43 + y44] = 2μ + 
(π1 − π2 + π3 + π4) + (2τB + λA) (see Table 4). 
The linear combination of (c1 − c2) − (c3 − c4) 
forms an unbiased estimate of treatment effect 
(λA − λB), while the linear combination of 2(c2 − 
c4) + (c1 − c3) forms an unbiased estimate of 
treatment effect (τA − τB). 
 
Discussion 
This article considered four two-treatment in 
four-period crossover designs. For a simple one 
period carryover effect model, the four designs 
presented    are    ideal    because    the    design  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
efficiencies are optimal. The designs with the 
highest efficiency (100%) are the AABB, ABBA 
and their duals (Table 2). The other designs 
considered weigh in at 91% (Hedayat & 
Stufken, 2003). All designs are robust, simple 
and easily implemented. 
Higher-order crossover designs are 
useful because they allow a treatment effect to 
be estimated even in the presence of a carry-over 
effect, they provide estimates of intra-subject 
variability and they draw inference on the carry-
over effect (Chow & Lu, 1992). Are these four-
period crossover designs useful? Perhaps. The 
true question relates to the application of these 
designs. 
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Table 1: Expected Values for Design I 
Sequence Period 1 (k = 1) 
Period 2 
(k = 2) 
Period 3 
(k = 3) 
Period 4 
(k = 4) 
ABBA 
(i = 1) y11 = μ + π1 + τA y21 = µ + π2 + τB + λA y31 = µ + π3 + τB + λB y14 = µ + π4 + τA + λB 
BAAB 
(i = 2) y21 = µ + π1 + τB y22 = µ + π2 + τA + λB Y23 = µ + π3 + τA + λA Y24 = µ + π4 + τB + λA 
 
Expected values for sequences: 
• ABBA, E[c1] = E[y11 + 2y12 + y13 + y14] = 5μ + (π1 + 2 π2 + π3 + π4) + (2τA +3 τB) + (2λA+2 λB) 
• BAAB, E[c2] = E[y21 + 2y22 + y32 - y42] = 5μ + (π1 + 2 π2 + π3 + π4) + (2τB +3 τA) + (2λA+2 λB) 
 
• ABBA, E[c3] = E(y11 − y12 + y13 − y14] = (π1 − π2 + π3 − π4) − λA 
• BAAB, E[c4] = E(y21 − y22 + y32 − y42] = (π1 − π2 + π3 − π4) − λB 
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Table 2: Expected Values for Design II: ABBA, AABB and Their Duals 
Sequence Period 1 (k = 1) 
Period 2 
(k = 2) 
Period 3 
(k = 3) 
Period 4 
(k = 4) 
ABBA 
(i = 1) µ + π1 + τA µ + π2 + τB + λA µ + π3 + τB + λB µ + π4 + τA + λB 
AABB 
(i = 2) µ + π1 + τA µ + π2 + τA + λA µ + π3 + τB + λA µ + π4 + τB + λB 
BAAB 
(i = 3) µ + π1 + τB µ + π2 + τA + λB µ + π3 + τA + λA µ + π4 + τB + λA 
BBAA 
(i = 4) µ + π1 + τB µ + π2 + τB + λB µ + π3 + τA + λB µ + π4 + τA + λA 
 
Expected values for sequences: 
• ABBA, E[c1] = E[y11 + y12 − y13 + y14] = 2μ + (π1 + π2 - π3 + π4) + (2τA +λA) 
• AABB, E[c2] = E[y21 + y22 − y23 + y24] = 2μ + (π1 + π2 - π3 + π4) + (2τA + λB) 
• BAAB, E[c3] = E[y31 + y32 −y33 + y34] = 2μ + (π1 + π2 - π3 + π4) + (2τB + λB) 
• BBAA, E[c4] = E[y41 + y42 − y43 + y44] = 2μ + (π1 + π2 - π3 + π4) + (2τB + λA) 
 
• ABBA, E[c5] = E[y11 + 2y12 + y13 + y14] = 5μ + (π1 + 2π2 + π3 + π4) + (2τA + 3τB) + (2λA+ 2λB) 
• AABB, E[c6] = E[y21 + 2y22 + y23 − y24] = 5μ + (π1 + 2π2 + π3 + π4) + (3τA + 2τB) + (3λA+ λB) 
• BAAB, E[c7] = E[y31 + 2y32 + y33 − y34] = 5μ + (π1 + 2π2 + π3 + π4) + (2τB + 3τA) + (2λA+ 2λB) 
• BBAA, E[c8] = E[y41 + 2y42 + y43 − y44] = 5μ + (π1 + 2π2 + π3 + π4) + (3τB + 2τA) + (λA+ 3λB) 
 
 
 
Table 3: Expected Values for Design III: ABBA, ABAA and Their Duals 
Sequence Period 1 (k = 1) 
Period 2 
(k = 2) 
Period 3 
(k = 3) 
Period 4 
(k=4) 
ABBA 
(i = 1) µ + π1 + τA µ + π2 + τB + λA µ + π3 + τB + λB µ + π4 + τA + λB 
ABAA 
(i = 2) µ + π1 + τA µ + π2 + τB + λA µ + π3 + τA + λB µ + π4 + τA + λA 
BAAB 
(i = 3) µ + π1 + τB µ + π2 + τA + λB µ + π3 + τA + λA µ + π4 + τB + λA 
BABB 
(i = 4) µ + π1 + τB µ + π2 + τA + λB µ + π3 + τB + λA µ + π4 + τB + λB 
 
Expected values for sequences: 
• ABBA, E[c1] = E[y11 + y12 + y13 − y14] = 2μ + (π1 + π2 + π3 − π4) + (2τB +λA) 
• ABAA, E[c2] = E[y21 + y22 + y23 − y24] = 2μ + (π1 + π2 + π3 − π4) + (τA + τB − λA + λB) 
• BAAB, E[c3] = E[y31 + y32 + y33 − y34] = 2μ + (π1 + π2 + π3 − π4) + (2τA + λB) 
• BABB, E[c4] = E[y41 + y42 + y43 − y44] = 2μ + (π1 + π2 + π3 − π4) + (τA + τB + λA − λB) 
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Table 4: Expected Values for Design IV: ABBA, ABAB and Their Duals 
Sequence Period 1 (k = 1) 
Period 2 
(k = 2) 
Period 3 
(k = 3) 
Period 4 
(k=4) 
ABBA 
(i = 1) µ + π1 + τA µ + π2 + τB + λA µ + π3 + τB + λB µ + π4 + τA + λB 
ABAB 
(i = 2) µ + π1 + τA µ + π2 + τB + λA µ + π3 + τA + λB µ + π4 + τB + λA 
BAAB 
(i = 3) µ + π1 + τB µ + π2 + τA + λB µ + π3 + τA + λA µ + π4 + τB + λA 
BABA 
(i = 4) µ + π1 + τB µ + π2 + τA + λB µ + π3 + τB + λA µ + π4 + τA + λB 
 
Expected values for sequences: 
• ABBA, E[c1] = E[y11 − y12 + y13 + y14] = 2μ + (π1 − π2 + π3 + π4) + (2τA + λB − λA) 
• ABAA, E[c2] = E[y21 − y22 + y23 + y24] = 2μ + (π1 − π2 + π3 + π4) + (2τA + λB) 
• BAAB, E[c3] = E[y31 − y32 + y33 + y34] = 2μ + (π1 − π2 + π3 + π4) + (2τB + λA − λB) 
• BABB, E[c4] = E[y41 − y42 + y43 + y44] = 2μ + (π1 − π2 + π3 + π4) + (2τB + λA) 
 
